Genéricas

QA CSV Specialist – GENETIC TESTING, BIOTECH We are a leading Genetic Testing Organisation seeking an experienced QA CSV Specialist to join our team working remotely on a permanent, Full-time [...]

Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces its collaboration with the Indiana University School of [...]

Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces a collaboration with the Academic Health Science Network for [...]

Oxford, UK. GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and [...]

OXFORD, England, January 11, 2022 (Newswire.com) – GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of [...]

GENETIC LAB TECHNICIAN – GENETIC TESTING, BIOTECH – ROYAL BROMPTON HOSPITAL, LONDON – FULL TIME, PERMANENT – BAND 4/5 EQUIVALENT, UP TO £30,000 PER YEAR + BENEFITS   We are a leading Genetic [...]

HCPC REGISTERED (GENETICS) CLINICAL SCIENTIST– GENETIC TESTING, BIOTECH – ROYAL BROMPTON HOSPITAL (RBHT), LONDON – FULL TIME, PERMANENT – BAND 7/8a EQUIVALENT, UP TO £52,000 PER YEAR + BENEFITS [...]

BIOINFORMATICIAN & SYSTEM ADMINISTRATOR IN MOLECULAR GENETICS DIAGNOSTICS, BIOTECH – LONDON – FULL TIME PERMANENT –  £47,000+ PER YEAR + BENEFITS We are a leading Genetic Testing organisation [...]

GENinCode Plc are pleased to announce the publication of its Thrombo inCode® prospective case-control study performed at the Karolinska Institute, Sweden. The positive clinical results strengthen [...]

GENinCode the predictive genetics and cardiovascular disease company focused on the prevention of cardiovascular disease is thrilled to announce the completion of its IPO and subsequent listing [...]

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces its partnership with EVERSANA Life Sciences LLC [...]

GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces today a collaboration with Royal Brompton and [...]

GENinCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes [...]

GENinCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the appointment of Paul Foulger [...]

Dr Luis Rincon’s performed his recent study into cardiovascular disease genetic risk scoring and its use to help predict secondary or recurrent cardiac events, after myocardial infarction, [...]

The 34th National Congress of the Italian Society for the Study of Atherosclerosis (SISA) took place virtually on the 22nd of November. The Congress addressed several topics of interest in the [...]

The much-anticipated UK Genomic Health Strategy has now been published! ‘The strategy sets out an ambitious and compelling vision for how to create the most advanced genomic healthcare [...]

On the 8th October our Scientific & Medical Manager, Dr Marta Carrera, attended as a key speaker at the Spanish Familial Hypercholesterolemia (FH) Foundation Conference presenting the [...]

World Heart Day (29th September) is an international, educational, campaign day for cardiovascular disease. Not just this day, but every day, lifestyle and preventative measures to reduce the [...]

GEN inCode UK Limited the privately owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease announces today the completion of a £3.0m [...]